Benzinga | Dec 11, 2021 05:50PM EST

Aptose Biosciences Published Poster - A Phase 1a/b Dose Escalation Study of Luxeptinib in R/R AML for ASH 2021

https://d1io3yog0oux5.cloudfront.net/_99b7257ac04fb6071711ec8134dd8aa2/aptose/db/776/7359/pdf/ASH2021_CG806-AML_Poster.pdf